阿里领投！腾讯跟投，押注“中国版Neuralink”_老虎社区_美港股上老虎

阿里领投！腾讯跟投，押注“中国版Neuralink”

中国基金报03-13 15:21

【导读】阶梯医疗完成5亿元C轮融资　　中国基金报记者莫琳　　3月13日早间，上海阶梯医疗科技有限公司（以下简称“阶梯医疗”）宣布完成5亿元战略融资。本轮融资由阿里巴巴领投，国投创合跟投；老股东腾讯、源来资本、奥博资本、元禾原点、启明创投、礼来亚洲基金、源码资本、上海国投先导持续跟投。　　阶梯医疗创始人李雪表示，互联网与科技“大厂”的深度入局具有里程碑式的意义：“双方的强强联合，将合力构建...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2619016914?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-13 15:21","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2619016914","market":"sh","top_or_hot":-1,"title":"阿里领投！腾讯跟投，押注“中国版Neuralink”","media":"中国基金报","content":"<div>\n<p>【导读】阶梯医疗完成5亿元C轮融资\n　　中国基金报记者 莫琳\n　　3月13日早间，上海阶梯医疗科技有限公司（以下简称“阶梯医疗”）宣布完成5亿元战略融资。本轮融资由阿里巴巴领投，国投创合跟投；老股东腾讯、源来资本、奥博资本、元禾原点、启明创投、礼来亚洲基金、源码资本、上海国投先导持续跟投。\n　　阶梯医疗创始人李雪表示，互联网与科技“大厂”的深度入局具有里程碑式的意义：“双方的强强联合，将合力构建...</p>\n\n<a href=\"https://finance.sina.com.cn/roll/2026-03-13/doc-inhqvnzk4155765.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>阿里领投！腾讯跟投，押注“中国版Neuralink”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n阿里领投！腾讯跟投，押注“中国版Neuralink”\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-13 15:21 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/roll/2026-03-13/doc-inhqvnzk4155765.shtml><strong>中国基金报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【导读】阶梯医疗完成5亿元C轮融资\n　　中国基金报记者 莫琳\n　　3月13日早间，上海阶梯医疗科技有限公司（以下简称“阶梯医疗”）宣布完成5亿元战略融资。本轮融资由阿里巴巴领投，国投创合跟投；老股东腾讯、源来资本、奥博资本、元禾原点、启明创投、礼来亚洲基金、源码资本、上海国投先导持续跟投。\n　　阶梯医疗创始人李雪表示，互联网与科技“大厂”的深度入局具有里程碑式的意义：“双方的强强联合，将合力构建...</p>\n\n<a href=\"https://finance.sina.com.cn/roll/2026-03-13/doc-inhqvnzk4155765.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0541502299.USD","symbol_name":"ALLSPRING  EMERGING MARKETS EQUITY \"I\" (USD) ACC","start_time":0,"source_url":"https://finance.sina.com.cn/roll/2026-03-13/doc-inhqvnzk4155765.shtml","article_id":"2619016914","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-03-13/doc-inhqvnzk4155765.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2619016914","pubTimestamp":1773386460,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"　　3月13日早间，上海阶梯医疗科技有限公司宣布完成5亿元战略融资。本轮融资由阿里巴巴领投，国投创合跟投；老股东腾讯、源来资本、奥博资本、元禾原点、启明创投、礼来亚洲基金、源码资本、上海国投先导持续跟投。目前，阶梯医疗是全球范围内第二家、中国第一家进入产品临床试验阶段的侵入式脑机接口公司。而相较于Neuralink，阶梯医疗的产品尺寸更小、柔软程度更高。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0541502299.USD":"ALLSPRING  EMERGING MARKETS EQUITY \"I\" (USD) ACC","LU0577902538.SGD":"Fullerton Lux Funds - Asia Growth and Income Equities A Acc SGD","LU2251237488.HKD":"TEMPLETON EMERGING MARKETS DYNAMIC INCOME \"A\" (HKD) INC A","KBAB":"2倍做多BABA ETF-KraneShares","IE00BZ08YT58.USD":"GUINNESS BEST OF CHINA \"C\" (USD) ACC","TCEHY":"腾讯控股ADR","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC","LU0588545904.SGD":"Eastspring Investments - Asian Equity Income ASDM SGD","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","BABO":"BABA期权收益策略ETF-YieldMax","LU0878004406.USD":"UBS (LUX) KEY SELEC ASIA ALLOCATION OPPORTUNITY (USD) \"P\" (USD) INC","LU0029874905.USD":"TEMPLETON EMERGING MARKETS \"A\" INC","LU1282649141.HKD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AMG\" (HKD) INC","BBYY":"GraniteShares YieldBOOST BABA ETF","LU0784639295.USD":"JPM ASIA PACIFIC INCOME \"A\" (USD) INC (M)","BABU":"Direxion Daily BABA Bull 2X ETF","IE0034224299.USD":"PINEBRIDGE ASIA EX JAPAN EQUITY \"A\" (USD) ACC","LU0819121731.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"AC\" (USD) ACC","LU0072913022.USD":"UBS (LUX) EQUITY FUND -  GREATER CHINA \"P\" (USD) ACC","BABW":"Roundhill BABA WeeklyPay ETF","LU0181495838.USD":"施罗德新兴亚洲A Acc","LU1303224171.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) INC","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","BABX":"2倍做多BABA ETF-GraniteShares","SG9999001903.USD":"Aberdeen Standard Pacific Equity USD","LU0052750758.USD":"富兰克林中国基金A Acc","LU0791591158.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"I\" (USD) ACC","LU1044874839.SGD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"AGH\" (SGDHDG) ACC","LU0348784397.USD":"ALLIANZ ORIENTAL INCOME \"A\" (USD) ACC","LU0972618739.USD":"JPM TOTAL EMERGING MARKETS  \"A\" (USD) INC (M)","HTCD.SI":"Tencent HK SDR 10to1","BK1589":"北水核心资产","LU1048596156.SGD":"Blackrock Asian Growth Leaders A2 SGD-H","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","00700":"腾讯控股","LU0561508036.HKD":"ALLIANZ CHINA EQUITY \"A\" (HKD) INC","09988":"阿里巴巴-W","LU1267930227.SGD":"TEMPLETON GLOBAL BALANCED \"AS\" (SGD) ACC A","IE00B8L5B284.USD":"BNY MELLON GLOBAL EMERGING MARKETS OPPORTUNITIES \"B\" (USD) INC","LU2051468812.USD":"JPM EMERGING MARKETS ESG EQUITY \"A\" (USD) ACC","BABA":"阿里巴巴","LU0823413660.USD":"BNP PARIBAS EMERGING EQUITY \"C\" (USD) INC","LU0651947912.USD":"BGF EMERGING MARKETS EQUITY INCOME \"A5G\" (USD) INC","LU1807302812.USD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (USD) ACC","BK1610":"ETF&股票定投概念","LU0608807433.USD":"TEMPLETON EMERGING MARKETS DYNAMIC INCOME \"A\" (USD) ACC","LU0164872284.USD":"HSBC GIF GLOBAL EMERGING MARKETS EQUITY \"A\" (USD) ACC","LU0345769631.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) INC"},"translate_title":"Ali led the vote! Tencent followed the investment, betting on \"Chinese version of Neuralink\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HTCD.SI":0.6,"BBYY":0.6,"BABA":1.5,"KBAB":0.6,"BABX":0.6,"BABW":0.6,"TCEHY":1.5,"TCHmain":1.5,"BABU":0.6,"00700":1.5,"BABO":0.6,"09988":0.6,"ALBmain":1.5},"content_text":"【导读】阶梯医疗完成5亿元C轮融资\n　　中国基金报记者 莫琳\n　　3月13日早间，上海阶梯医疗科技有限公司（以下简称“阶梯医疗”）宣布完成5亿元战略融资。本轮融资由阿里巴巴领投，国投创合跟投；老股东腾讯、源来资本、奥博资本、元禾原点、启明创投、礼来亚洲基金、源码资本、上海国投先导持续跟投。\n　　阶梯医疗创始人李雪表示，互联网与科技“大厂”的深度入局具有里程碑式的意义：“双方的强强联合，将合力构建出新一代智能脑机接口系统及丰富前沿应用生态。这不仅是对医疗创新的支持，更是对下一代人机交互底层能力的提前布局。”\n　　“中国版Neuralink”冲刺商业化\n　　成立于2021年的阶梯医疗在诞生之日，就对标埃隆·马斯克的脑机接口公司Neuralink。\n　　在技术路线上，阶梯医疗与Neuralink一样、选择了难度最高的脑机接口侵入式技术路线。目前，阶梯医疗是全球范围内第二家（仅次于Neuralink）、中国第一家进入产品临床试验阶段的侵入式脑机接口公司。而相较于Neuralink，阶梯医疗的产品尺寸更小、柔软程度更高。\n　　对此，阶梯医疗创始人、中国科学院脑智卓越中心研究员赵郑拓博士在接受记者采访时表示，对于脑机接口而言，从非侵入、半侵入到侵入式，技术难度逐步提高，应用价值也随之逐步提高。“我们阶梯医疗从一开始就希望能够解决开发难度最高、应用价值最高的那一类问题。”\n　　2025年3月11日，国家医保局发布《神经系统类医疗服务价格项目立项指南（试行）》，其中专门为脑机接口新技术前瞻性单独立项，设立了“侵入式脑机接口置入费”“侵入式脑机接口取出费”“非侵入式脑机接口适配费”等价格项目。脑机接口产品进入临床应用的收费路径正变得清晰。\n　　自此，阶梯医疗开始在商业化与临床落地进程上发起冲刺。\n　　继去年成功完成3例脑机接口临床试验后，阶梯医疗今年的临床进程进一步提速：2026年初，依托公司自主研发的手术机器人，阶梯医疗已成功完成拟注册256通道无线高通量侵入式脑机接口系统（WRS02）的临床植入，并获得脑控交互功能的有效验证。\n　　李雪透露，公司计划于2026年中开展大规模多中心注册临床试验，计划年内完成规模约40例患者的入组及植入手术。到2026年底，阶梯医疗的临床植入总例数有望接近甚至反超马斯克旗下Neuralink目前的临床试验总量（当前约21例）。\n　　阿里、腾讯押注\n　　天眼查显示，成立于2021年8月的阶梯医疗已经完成5轮融资。值得一提的是，阶梯医疗近一年内累计融资额超过11亿元，也是阿里和腾讯在脑机接口领域布局的企业。\n\n　　据记者此前了解，自去年3月国家医保局发布《神经系统类医疗服务价格项目立项指南（试行）》之后，国内掀起了一轮对脑机接口的投资热潮，但大多数的投资人仍然对估值10亿元或者1亿美元以上的项目保持谨慎。\n　　对于大多数投资人而言，脑机接口的“首证”获批可能是一个争夺的目标。2026年初，阶梯医疗成功完成拟注册256通道无线高通量侵入式脑机接口系统（WRS02）的临床植入，该系统也是目前国内唯一获批进入国家药监局创新医疗器械“绿色通道”的侵入式脑机接口产品。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：宋雅芳","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}